Corrie A Painter
Overview
Explore the profile of Corrie A Painter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
2313
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wisdom A, Raut C, Haddox C, Hornick J, Jagannathan J, Painter C, et al.
Cancer
. 2025 Feb;
131(5):e35772.
PMID: 39980372
Soft tissue sarcomas are a rare group of mesenchymal malignancies, with greater than 100 histologic subtypes. Advancements in understanding these subtypes has enabled histology-tailored management. This primer describes the workup...
2.
Bhakhri P, Phelps K, Gomez Tejeda Zanudo J, Gwozdz E, Ko S, Hendrickson T, et al.
Ther Adv Rare Dis
. 2024 Dec;
5:26330040241304440.
PMID: 39691183
Background: Approximately 25% of cancer patients are diagnosed with rare cancers and face unique challenges. Decentralized patient-partnered research efforts, like Count Me In provide an avenue for patients to participate...
3.
Crowdis J, Balch S, Sterlin L, Thomas B, Camp S, Dunphy M, et al.
Cell Genom
. 2022 Sep;
2(9).
PMID: 36177448
Molecular profiling studies have enabled discoveries for metastatic prostate cancer (MPC) but have predominantly occurred in academic medical institutions and involved non-representative patient populations. We established the Metastatic Prostate Cancer...
4.
Wagner M, Hennessy C, Beeghly A, French B, Shah D, Croessmann S, et al.
Cancers (Basel)
. 2022 Sep;
14(17).
PMID: 36077869
Background: Patients with sarcoma often require individualized treatment strategies and are likely to receive aggressive immunosuppressive therapies, which may place them at higher risk for severe COVID-19. We aimed to...
5.
Rebbeck T, Bridges J, Mack J, Gray S, Trent J, George S, et al.
JAMA Health Forum
. 2022 Jun;
3(4).
PMID: 35755401
Importance: Research into the genetic and genomic ("genomics") foundations of disease is central to our understanding of disease prevention, early detection, diagnostic accuracy, and therapeutic intervention. Inequitable participation in genomics...
6.
Anampa-Guzman A, Freeman-Daily J, Fisch M, Lou E, Pennell N, Painter C, et al.
JCO Oncol Pract
. 2022 Mar;
18(8):578-583.
PMID: 35344398
Purpose: Patients who have cancer have leveraged the Internet to gain a better understanding of their disease and connect across geographic boundaries with others facing the same challenges. Online cancer...
7.
Fu J, Reid S, French B, Hennessy C, Hwang C, Gatson N, et al.
JAMA Netw Open
. 2022 Mar;
5(3):e224304.
PMID: 35344045
Importance: Non-Hispanic Black individuals experience a higher burden of COVID-19 than the general population; hence, there is an urgent need to characterize the unique clinical course and outcomes of COVID-19...
8.
Li A, Kuderer N, Hsu C, Shyr Y, Warner J, Shah D, et al.
J Thromb Haemost
. 2021 Jul;
19(10):2522-2532.
PMID: 34260813
Background: Hospitalized patients with COVID-19 have increased risks of venous (VTE) and arterial thromboembolism (ATE). Active cancer diagnosis and treatment are well-known risk factors; however, a risk assessment model (RAM)...
9.
Bakouny Z, Hawley J, Choueiri T, Peters S, Rini B, Warner J, et al.
Cancer Cell
. 2020 Oct;
38(5):629-646.
PMID: 33049215
Patients with cancer have been disproportionately affected by the COVID-19 pandemic. This effect has included the adverse outcomes in patients with cancer who develop COVID-19, the impact of the COVID-19...
10.
Damas J, Hughes G, Keough K, Painter C, Persky N, Corbo M, et al.
Proc Natl Acad Sci U S A
. 2020 Aug;
117(36):22311-22322.
PMID: 32826334
The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of COVID-19. The main receptor of SARS-CoV-2, angiotensin I converting enzyme 2 (ACE2), is now undergoing extensive...